Integrative analysis of SEC13: a prognostic predictor and immunotherapeutic target

Key Points

• SEC13 serves as a prognostic predictor for various cancers, enhancing understanding of tumor progression.
• Increased SEC13 expression in the tumor microenvironment correlates with a stronger immune response.
• Integration of multi-omics data allows for a comprehensive assessment of SEC13's role in cancer biology.
• This study highlights the potential of SEC13 as an immunotherapeutic target in clinical settings.